Financial reports
ARS
2023 FY
Annual report to shareholders
16 Apr 24
10-K
2023 FY
Annual report
23 Feb 24
10-Q
2023 Q3
Quarterly report
1 Nov 23
10-Q
2023 Q2
Quarterly report
2 Aug 23
10-Q
2023 Q1
Quarterly report
4 May 23
ARS
2022 FY
Annual report to shareholders
18 Apr 23
10-K
2022 FY
Annual report
24 Feb 23
10-Q
2022 Q3
Quarterly report
3 Nov 22
10-Q
2022 Q2
Quarterly report
4 Aug 22
10-Q
2022 Q1
Quarterly report
5 May 22
Current reports
8-K
Investor Presentation February 2024
28 Feb 24
8-K
Glaukos Announces Fourth Quarter and Full Year 2023 Financial Results
21 Feb 24
8-K
Glaukos Announces Preliminary, Unaudited Fourth Quarter and Full Year 2023 Net Sales and Reaffirms 2024 Revenue Guidance
9 Jan 24
8-K
Revolutionary, micro-invasive, injectable treatment for the full range of glaucoma disease severity
14 Dec 23
8-K
Glaukos Announces Third Quarter 2023 Financial Results
1 Nov 23
8-K
Investor Presentation August 2023
18 Aug 23
8-K
Glaukos Announces Second Quarter 2023 Financial Results
2 Aug 23
8-K
Submission of Matters to a Vote of Security Holders
7 Jun 23
8-K
Investor Presentation May 2023
17 May 23
8-K
Glaukos Announces First Quarter 2023 Financial Results
3 May 23
Registration and prospectus
S-8
Registration of securities for employees
15 Mar 24
S-8
Registration of securities for employees
10 Mar 23
S-8 POS
Registration of securities for employees (post-effective amendment)
18 Mar 22
S-8
Registration of securities for employees
8 Mar 22
S-8
Registration of securities for employees
11 Mar 21
S-8
Registration of securities for employees
9 Mar 20
S-8 POS
Registration of securities for employees (post-effective amendment)
21 Nov 19
425
Business combination disclosure
14 Nov 19
425
Business combination disclosure
7 Nov 19
425
Business combination disclosure
6 Nov 19
Proxies
DEF 14A
Definitive proxy
16 Apr 24
DEFA14A
Additional proxy soliciting materials
16 Apr 24
DEFA14A
Additional proxy soliciting materials
18 Apr 23
DEF 14A
Definitive proxy
18 Apr 23
DEFA14A
Additional proxy soliciting materials
19 Apr 22
DEF 14A
Definitive proxy
19 Apr 22
DEF 14A
Definitive proxy
22 Apr 21
DEFA14A
Additional proxy soliciting materials
24 Apr 20
DEF 14A
Definitive proxy
24 Apr 20
DEFA14A
Additional proxy soliciting materials
17 Apr 19
Other
SD
Conflict minerals disclosure
31 May 23
SD
Conflict minerals disclosure
27 May 22
SD
Conflict minerals disclosure
28 May 21
SD
Conflict minerals disclosure
29 May 20
UPLOAD
Letter from SEC
1 May 20
CORRESP
Correspondence with SEC
23 Apr 20
UPLOAD
Letter from SEC
13 Apr 20
EFFECT
Notice of effectiveness
18 Oct 19
CORRESP
Correspondence with SEC
15 Oct 19
CORRESP
Correspondence with SEC
15 Oct 19
Ownership
4
David F Hoffmeister
12 Apr 24
4
Joseph E Gilliam
10 Apr 24
4
Alex R. Thurman
9 Apr 24
4
Joseph E Gilliam
9 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
144
Notice of proposed sale of securities
8 Apr 24
4
Joseph E Gilliam
5 Apr 24
4
Alex R. Thurman
5 Apr 24
144
Notice of proposed sale of securities
5 Apr 24
144
Notice of proposed sale of securities
5 Apr 24